日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Hormone therapy enhances anti-PD1 efficacy in premenopausal estrogen receptor-positive and HER2-negative advanced breast cancer

激素疗法可增强抗PD-1疗法对绝经前雌激素受体阳性、HER2阴性晚期乳腺癌的疗效

期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2024.101879
Chen, I-Chun; Lin, Ching-Hung; Chang, Dwan-Ying; Wei-Wu Chen, Tom; Wang, Ming-Yang; Ma, Wei-Li; Lin, Yi-Ting; Huang, Shu-Min; Hsu, Chia-Lang; Lu, Yen-Shen
肿瘤
HER2
肿瘤免疫
信号转导
乳腺癌
PD-1
免疫/内分泌
发表日期：2025
文献求助 收藏

Seneca Valley virus replicons are packaged in trans and have the capacity to overcome the limitations of viral transgene expression

塞内卡谷病毒复制子被包装成反式，有能力克服病毒转基因表达的局限性

期刊:Molecular Therapy-Oncolytics
影响因子:5.3
doi:10.1016/j.omto.2023.02.005
Jeffrey D Bryant, Jennifer S Lee, Ana De Almeida, Judy Jacques, Ching-Hung Chang, William Fassler, Christophe Quéva, Lorena Lerner, Edward M Kennedy
微生物学
发表日期：2023
文献求助 收藏

Plasma cell-free tumor DNA, PIK3CA and TP53 mutations predicted inferior endocrine-based treatment outcome in endocrine receptor-positive metastatic breast cancer

血浆游离肿瘤DNA、PIK3CA和TP53突变预示着内分泌受体阳性转移性乳腺癌患者内分泌治疗效果较差

期刊:Breast Cancer Research and Treatment
影响因子:3
doi:10.1007/s10549-023-06967-3
Chen, Tom Wei-Wu; Hsiao, Wen; Dai, Ming-Shen; Lin, Ching-Hung; Chang, Dwan-Ying; Chen, I-Chun; Wang, Ming-Yang; Chang, Shu-Han; Huang, Shu-Min; Cheng, Ann-Lii; Wu, Ko-Wen; Tan, Kien Thiam; Lu, Yen-Shen
肿瘤
肿瘤免疫
信号转导
乳腺癌
P53
发表日期：2023
文献求助 收藏